Knee replacement pain relief showdown: which numbing cocktail wins?

NCT ID NCT07509866

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests three different numbing medicine combinations for pain after total knee replacement. 90 adults having knee surgery will get one of three options: a long-acting numbing drug, or a standard numbing drug plus one of two additives. The goal is to see which approach reduces the need for opioid painkillers and helps people get moving sooner.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Liposomal bupivacaine, ropivacaine with dexamethasone, ropivacaine with dexmedetomidine
What this could lead to
If successful, this could identify the most effective numbing approach for knee replacement surgery, leading to less pain, less opioid use, and faster recovery.
What could go wrong
This is a small, early-stage trial with only 90 participants, so results may not apply to everyone. The different numbing methods may work similarly, and unexpected side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIPOSOMAL BUPIVACAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    RECRUITING

    Wuhan, Hubei, 430022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.